Literature DB >> 9733926

The structuring effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers: a differential scanning calorimetry study.

I Fournier1, J Barwicz, P Tancrède.   

Abstract

Amphotericin B (AmB) is the most widely used polyene antibiotic to treat systemic fungal infections which affect an increasing number of immunocompromised patients. It is generally thought that AmB forms pores within the fungi membranes by interacting with ergosterol, the main sterol of fungi. However, it also interacts with the cholesterol contained in mammalian cells, hence its toxicity. In order to have a better understanding of the interactions prevailing between AmB and sterols, differential scanning calorimetry was used to study various mixtures incorporating from 6.5 to 25 mol% of AmB in pure dipalmitoylphosphatidylcholine (DPPC) vesicles and in ergosterol- or cholesterol-containing DPPC vesicles. The sterol concentration was kept constant at 12.5 mol% with respect to the phospholipid. Our results show that three phases co-exist when AmB is dispersed in the pure phospholipid. One corresponds to the phospholipid phase alone. The two others are characterised by a broad transition at temperatures higher than the main transition temperature of the pure phospholipid, corresponding to the drug in interaction with the aliphatic chains of the lipid. The fact that the transition temperatures of these additional components are higher than that of the pure phospholipid suggests that AmB interacts strongly with the aliphatic chains of the lipid, consistent with the idea prevailing in the literature that AmB by itself may form pores in a lipid matrix. When AmB interacts with cholesterol-containing bilayers the thermograms also present three components. Upon increasing the concentration of AmB, though, an important broadening of these components is observed which is explained in terms of destabilisation of the organisation of the aliphatic chains. The situation is strikingly different if ergosterol is present in the lipid matrix. The thermograms remain unmodified as the concentration of AmB is increased and a broad transition, now involving only two components when the thermograms are decomposed, is observed. An analysis of the results shows that various interacting units, e.g. AmB+DPPC and (AmB+ergosterol)+DPPC, are present within the membrane. These units involve the phospholipid and hence contribute to its structurisation. The important differences between the thermograms obtained with the ergosterol- as compared to the cholesterol-containing bilayers, in spite of the structural similarity of these two sterols, provides strong evidence for the selectivity of interaction of AmB with ergosterol as compared to cholesterol. It is thus clear that the action of AmB on cholesterol- as compared to ergosterol-containing membranes results from different mechanisms. Finally, UV-visible spectra of AmB in pure as well as sterol-containing DPPC vesicles show the presence of absorption bands that give support to the interpretation derived from the calorimetric data.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733926     DOI: 10.1016/s0005-2736(98)00083-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  The interaction of dipole modifiers with amphotericin-ergosterol complexes. Effects of phospholipid and sphingolipid membrane composition.

Authors:  Olga S Ostroumova; Svetlana S Efimova; Ekaterina V Mikhailova; Ludmila V Schagina
Journal:  Eur Biophys J       Date:  2014-02-23       Impact factor: 1.733

2.  Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B.

Authors:  Thomas A Diezi; Glen Kwon
Journal:  Pharm Res       Date:  2011-12-01       Impact factor: 4.200

3.  Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.

Authors:  Cécile Ménez; Marion Buyse; Madeleine Besnard; Robert Farinotti; Philippe M Loiseau; Gillian Barratt
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

4.  Cooperative partition model of nystatin interaction with phospholipid vesicles.

Authors:  Ana Coutinho; Manuel Prieto
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

5.  Molecular aspects of the interaction between amphotericin B and a phospholipid bilayer: molecular dynamics studies.

Authors:  Kamil Sternal; Jacek Czub; Maciej Baginski
Journal:  J Mol Model       Date:  2004-04-30       Impact factor: 1.810

6.  Ion channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy.

Authors:  Weimin Huang; Zheling Zhang; Xiaojun Han; Jilin Tang; Jianguo Wang; Shaojun Dong; Erkang Wang
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

7.  FTIR spectroscopic study of molecular organization of the antibiotic amphotericin B in aqueous solution and in DPPC lipid monolayers containing the sterols cholesterol and ergosterol.

Authors:  Mariusz Gagoś; Marta Arczewska
Journal:  Eur Biophys J       Date:  2012-07-26       Impact factor: 1.733

8.  Towards New Insights in the Sterol/Amphotericin Nanochannels Formation: A Molecular Dynamic Simulation Study.

Authors:  Khaoula Boukari; Sébastien Balme; Jean-Marc Janot; Fabien Picaud
Journal:  J Membr Biol       Date:  2015-12-23       Impact factor: 1.843

9.  Investigation of channel-forming activity of polyene macrolide antibiotics in planar lipid bilayers in the presence of dipole modifiers.

Authors:  S S Efimova; L V Schagina; O S Ostroumova
Journal:  Acta Naturae       Date:  2014-10       Impact factor: 1.845

10.  Recognition of Membrane Sterols by Polyene Antifungals Amphotericin B and Natamycin, A (13)C MAS NMR Study.

Authors:  Filip Ciesielski; David C Griffin; Jessica Loraine; Michael Rittig; Joss Delves-Broughton; Boyan B Bonev
Journal:  Front Cell Dev Biol       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.